Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NeuroOne Medical Technolo...

    NASDAQ: NMTC · Real-Time Price · USD
    0.56
    -0.01 (-2.44%)
    At close: Jun 13, 2025, 3:59 PM
    0.59
    5.07%
    After-hours: Jun 13, 2025, 05:59 PM EDT

    NeuroOne Medical Statistics

    Share Statistics

    NeuroOne Medical has 49.82M shares outstanding. The number of shares has increased by 10.85% in one year.

    Shares Outstanding

    n/a
    		 49.82M

    Shares Change (YoY)

    n/a
    		 10.85%

    Shares Change (QoQ)

    n/a
    		 0.07%

    Owned by Institutions (%)

    n/a
    		 6.05%

    Shares Floating

    n/a
    		 43.85M

    Failed to Deliver (FTD) Shares

    n/a
    		 69,505

    FTD / Avg. Volume

    n/a
    		 23.22%

    Short Selling Information

    The latest short interest is 198.1K, so 0.4% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 198.1K

    Short % of Shares Out

    n/a
    		 0.4%

    Short % of Float

    n/a
    		 0.41%

    Short Ratio (days to cover)

    n/a
    		 1.2

    Valuation Ratios

    The PE ratio is -2.15 and the forward PE ratio is -3.87. NeuroOne Medical's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -2.15

    Forward PE

    n/a
    		 -3.87

    PS Ratio

    n/a
    		 7.67

    Forward PS

    n/a
    		 1.2

    PB Ratio

    n/a
    		 32.23

    P/FCF Ratio

    n/a
    		 -2.38

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for NeuroOne Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.32.

    Current Ratio

    n/a
    		 2.09

    Quick Ratio

    n/a
    		 0.9

    Debt / Equity

    n/a
    		 0.32

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 -51.91

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $203,117.82

    Profits Per Employee

    n/a
    		 $-724,594.71

    Employee Count

    n/a
    		 17

    Asset Turnover

    n/a
    		 0.64

    Inventory Turnover

    n/a
    		 0.9

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -41.31% in the last 52 weeks. The beta is 0.72, so NeuroOne Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.72

    52-Week Price Change

    n/a
    		 -41.31%

    50-Day Moving Average

    n/a
    		 0.59

    200-Day Moving Average

    n/a
    		 0.84

    Relative Strength Index (RSI)

    n/a
    		 40

    Average Volume (20 Days)

    n/a
    		 299,288

    Income Statement

    In the last 12 months, NeuroOne Medical had revenue of 3.45M and earned -12.32M in profits. Earnings per share was -0.46.

    Revenue

    n/a
    		 3.45M

    Gross Profit

    n/a
    		 1.08M

    Operating Income

    n/a
    		 -11.89M

    Net Income

    n/a
    		 -12.32M

    EBITDA

    n/a
    		 -11.84M

    EBIT

    n/a
    		 -12.09M

    Earnings Per Share (EPS)

    n/a
    		 -0.46
    Full Income Statement

    Balance Sheet

    The company has 1.46M in cash and 260.16K in debt, giving a net cash position of 1.2M.

    Cash & Cash Equivalents

    n/a
    		 1.46M

    Total Debt

    n/a
    		 260.16K

    Net Cash

    n/a
    		 1.2M

    Retained Earnings

    n/a
    		 -75M

    Total Assets

    n/a
    		 4.46M

    Working Capital

    n/a
    		 1.99M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -11.01M and capital expenditures -120.2K, giving a free cash flow of -11.13M.

    Operating Cash Flow

    n/a
    		 -11.01M

    Capital Expenditures

    n/a
    		 -120.2K

    Free Cash Flow

    n/a
    		 -11.13M

    FCF Per Share

    n/a
    		 -0.42
    Full Cash Flow Statement

    Margins

    Gross margin is 31.27%, with operating and profit margins of -344.26% and -356.74%.

    Gross Margin

    n/a
    		 31.27%

    Operating Margin

    n/a
    		 -344.26%

    Pretax Margin

    n/a
    		 -356.74%

    Profit Margin

    n/a
    		 -356.74%

    EBITDA Margin

    n/a
    		 -342.96%

    EBIT Margin

    n/a
    		 -344.26%

    FCF Margin

    n/a
    		 -322.39%

    Dividends & Yields

    NMTC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NMTC is $1.45, which is 158.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $1.45

    Price Target Difference

    n/a
    		 158.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 1, 2021. It was a backward split with a ratio of 1:3.

    Last Split Date

    n/a
    		 Apr 1, 2021

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:3

    Scores

    Altman Z-Score

    n/a
    		 -20.47

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist